KAM
REGN icon

Karani Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Karani Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,512
Closed -$959K – 47
2025
Q1 		$959K Sell
1,512
-811
-35% -$558K 1.02% 28
2024
Q4 		$1.65M Buy
+2,323
New +$1.95M 1.54% 22
2023
Q3 		$4.43M Sell
5,378
-2,267
-30% -$1.78M 6.37% 3
2023
Q2 		$5.49M Sell
7,645
-230
-3% -$177K 5.54% 3
2023
Q1 		$6.47M Buy
7,875
+135
+2% +$102K 6.85% 2
2022
Q4 		$5.58M Sell
7,740
-2,185
-22% -$1.61M 6.51% 1
2022
Q3 		$6.84M Sell
9,925
-2,085
-17% -$1.31M 6.93% 1
2022
Q2 		$7.1M Sell
12,010
-3,365
-22% -$2.19M 6.56% 2
2022
Q1 		$10.7M Buy
15,375
+415
+3% +$263K 5.81% 4
2021
Q4 		$9.45M Buy
14,960
+3,717
+33% +$2.29M 4.67% 7
2021
Q3 		$6.8M Buy
11,243
+289
+3% +$179K 3.3% 10
2021
Q2 		$6.12M Buy
10,954
+53
+0.5% +$26.9K 3.16% 19
2021
Q1 		$5.16M Buy
10,901
+1,127
+12% +$549K 3.04% 18
2020
Q4 		$4.72M Sell
9,774
-151
-2% -$81.5K 2.79% 16
2020
Q3 		$5.56M Hold
9,925
– – 3.73% 5
2020
Q2 		$6.19M Sell
9,925
-260
-3% -$148K 4.8% 4
2020
Q1 		$4.97M Sell
10,185
-3,607
-26% -$1.49M 5.32% 4
2019
Q4 		$5.18M Buy
+13,792
New +$4.64M 4.8% 6

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Karani Asset Management's REGN Position: Q2 2025 in Review

Karani Asset Management sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 1,512 shares — an estimated $959K sold.

Karani Asset Management first reported a position in REGN in Q4 2019 and held it in 18 quarters. The position peaked at $10.7M in Q1 2022. 1,202 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

  • Karani Asset Management reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Karani Asset Management sold 1,512 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $959K.
  • Karani Asset Management first reported a position in Regeneron Pharmaceuticals in Q4 2019 and held it in 18 quarters.
  • Karani Asset Management's Regeneron Pharmaceuticals position peaked at $10.7M in Q1 2022.
  • 1,202 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Karani Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.